The Ezh2 knockdown plasmid was co‐injected with the Akt/NICD1 plasmid to observe whether the knockdown of Ezh2 had an inhibitory effect on the progression of CCA in vivo. This evidence concerns the gene AKT1 and cholangiocarcinoma.